Viewing Study NCT00100061



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00100061
Status: UNKNOWN
Last Update Posted: 2013-03-12
First Post: 2004-12-22

Brief Title: Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections UTIs
Sponsor: National Center for Complementary and Integrative Health NCCIH
Organization: National Center for Complementary and Integrative Health NCCIH

Study Overview

Official Title: Dose Response to Cranberry of Women With Recurrent UTIs
Status: UNKNOWN
Status Verified Date: 2013-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the role of cranberry-containing products in preventing urinary tract infections UTIs
Detailed Description: Although cranberry-containing products are commonly taken to prevent UTIs and other urinary symptoms an optimally effective dose has not been established and the chemicals responsible for the UTI-preventing properties in cranberry-containing products have yet to be determined This study will determine the minimum dose of cranberry-containing product necessary to prevent UTIs the effectiveness of cranberry-containing products in fighting different strains of E coli and the long-term effects of cranberry-containing product consumption This study will also determine whether plant pigments called proanthocyanidins influence the UTI-preventing properties of cranberry-containing products

This study will last 2 years Participants will be randomly assigned to receive varying doses of either cranberry-containing products or placebo for 1 year Some participants will receive cranberry or placebo supplement tablets others will receive cranberry juice or a placebo beverage Clinic visits will occur every 2 months urine collection will occur at each visit Some participants will be asked to collect 24-hour urine samples every 8 weeks and provide urine samples on Days 1 3 5 and 7

Laboratory tests will be used to assess participants during the study A 3-day course of antibiotics will be provided to participants developing a UTI during the course of the study Telephone interview follow-up at 6 and 12 months after the study will determine whether cranberry-containing product use has continued and whether UTIs have recurred

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None